[EN] MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF<br/>[FR] ACTIVATEURS DE LA MITOFUSINE ET LEURS PROCÉDÉS D'UTILISATION
申请人:MITOCHONDRIA EMOTION INC
公开号:WO2020159576A1
公开(公告)日:2020-08-06
Compositions including small molecule mitofusin activators are described. The mitofusin activators are useful for treating diseases or disorders associated with a mitochondria-associated disease, disorder, or condition such as diseases or disorders associated with mitofusin 1 (MFN1) and/or mitofusin 2 (MFN2), or mitochondrial dysfunction. Methods of treatment, pharmaceutical formulations, and screening methods for identifying compounds that activate mitochondrial fusion are also described.